At a glance
ClinicalIndex Comparison RecordN/ACompleted· 86 enrolled
Drug / intervention
LiquID GCE Usedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
LiquID Guide Catheter Extension Safety Study
In Brief
A clinical study evaluating LiquID GCE Use for Coronary Artery Disease. Completed, enrolled 86 participants across 8 sites in 3 countries.
Detailed Summary
Single arm, open label, historically controlled, multicenter study evaluating the primary safety and performance of the LiquID Guide Catheter Extension
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesBelgium, Ireland, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJun 2022
Enrollment StartOct 2022
Primary CompletionOct 2023
Study CompletionOct 2023
TodayJul 2026
First PostedJun 6, 2022
Enrollment StartOct 13, 2022
Primary CompletionOct 12, 2023
Study CompletionOct 20, 2023
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 4.1 years ago
Interventions
LiquID GCE Usedevice
Use of the LiquID GCE to aid in percutaneous coronary intervention (PCI)